Company · CIK 0001607678 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Viking Therapeutics, Inc. · VKTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 AForm 4 → | Aug 7, 4:34 pm EDT | Dorothy Elizabeth Kelly-GemmellDirector | 6,333 | — | — | 6,333 | — | late |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:07 pm EDT | Brian LianPresident & CEO, Director | 148,517 | $33.32 | $4,947,888 | 2,572,441 | −5.46% | |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:06 pm EDT | Greg ZanteChief Financial Officer | 21,217 | $33.47 | $710,141 | 212,204 | −9.09% | |
| Jul 29, 2026 SForm 4 → | Jul 29, 8:06 pm EDT | Marianna ManciniChief Operating Officer | 18,217 | $33.47 | $609,636 | 422,760 | −4.13% | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:07 pm EDT | Brian LianPresident & CEO, Director | 221,667 | — | — | 2,720,958 | — | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:06 pm EDT | Greg ZanteChief Financial Officer | 31,667 | — | — | 233,421 | — | |
| Jul 28, 2026 AForm 4 → | Jul 29, 8:06 pm EDT | Marianna ManciniChief Operating Officer | 31,667 | — | — | 440,977 | — | |
| Jan 19, 2019 FForm 4 → | Jan 22, 7:13 pm EST | Michael MorneauVP, Finance and Administration | 2,044 | $8.78 | $17,946 | 91,991 | — | plan? |
| Jan 19, 2019 FForm 4 → | Jan 22, 7:13 pm EST | Brian LianPresident & CEO, Director | 4,333 | $8.78 | $38,044 | 1,560,152 | — | plan? |
| Jan 3, 2019 AForm 4 → | Jan 3, 8:33 pm EST | Hiroko MasamuneChief Development Officer | 22,667 | — | — | 141,063 | — | plan? |
| Jan 3, 2019 AForm 4 → | Jan 3, 8:31 pm EST | Brian LianPresident & CEO, Director | 80,897 | — | — | 1,564,485 | — | plan? |
| Sep 25, 2018 SForm 4 → | Sep 27, 9:25 pm EDT | LIGAND PHARMACEUTICALS INC10% Owner | 262,881 | $19.15 | $5,034,250 | 6,038,083 | −4.17% | plan? |
| Jul 1, 2018 AForm 4 → | Jul 3, 5:25 pm EDT | Hiroko MasamuneChief Development Officer | 15,000 | — | — | 111,197 | — | plan? |
| May 31, 2018 PForm 4 → | May 31, 7:04 pm EDT | J Matthew SingletonDirector | 9,500 | $9.82 | $93,261 | 9,500 | — | plan? |
| May 31, 2018 SForm 4 → | May 31, 7:03 pm EDT | Michael MorneauVP, Finance and Administration | 21,551 | $9.25 | $199,347 | 94,035 | −18.6% | plan? |
| May 29, 2018 PForm 4 → | May 31, 7:02 pm EDT | Charles A Rowland Jr.Director | 30,000 | $5.16 | $154,800 | 30,000 | — | plan? |
| May 29, 2018 PForm 4 → | May 31, 6:59 pm EDT | Stephen W WebsterDirector | 8,000 | $5.21 | $41,712 | 8,000 | — | plan? |
| May 29, 2018 PForm 4 → | May 31, 6:57 pm EDT | Lawson MacartneyDirector | 47,965 | $5.22 | $250,329 | 47,965 | — | plan? |
| May 4, 2018 FForm 4 → | May 8, 8:37 pm EDT | Michael MorneauVP, Finance and Administration | 7,616 | $4.22 | $32,140 | 94,035 | — | plan? |
| May 4, 2018 FForm 4 → | May 8, 8:37 pm EDT | Brian LianPresident & CEO, Director | 10,086 | $4.22 | $42,563 | 1,483,012 | — | plan? |
| Jan 19, 2018 AForm 4 → | Jan 23, 5:42 pm EST | Michael MorneauChief Financial Officer | 15,000 | — | — | 101,651 | — | plan? |
| Jan 19, 2018 AForm 4 → | Jan 23, 5:41 pm EST | Brian LianPresident & CEO, Director | 40,000 | — | — | 1,493,098 | — | plan? |
| May 4, 2017 FForm 4 → | May 5, 6:25 pm EDT | Michael MorneauChief Financial Officer | 8,192 | $1.34 | $10,977 | 80,604 | — | plan? |
| Nov 15, 2016 PForm 4 → | Nov 15, 4:34 pm EST | Matthew W FoehrDirector | 13,000 | $1.21 | $15,678 | 39,250 | +49.5% | plan? |
| May 4, 2016 FForm 4 → | May 5, 5:36 pm EDT | Rochelle HanleyChief Medical Officer | 10,595 | $1.31 | $13,879 | 160,836 | — | plan? |
| Apr 13, 2016 ACForm 4 → | Apr 15, 5:19 pm EDT | LIGAND PHARMACEUTICALS INC10% Owner | 1,520,000 | $1.25 | $1,200,000 | 6,300,964 | — | plan? |
| Apr 13, 2016 PForm 4 → | Apr 13, 6:17 pm EDT | Matthew W FoehrDirector | 20,000 | $1.24 | $24,800 | 26,250 | +320% | plan? |
| May 28, 2015 JForm 4 → | Jun 1, 4:09 pm EDT | LIGAND PHARMACEUTICALS INC10% Owner | 228,105 | — | — | 4,780,964 | — | plan? |
| May 4, 2015 ACDFForm 4 → | May 6, 8:20 pm EDT | Brian LianPresident & CEO, Director | 2,429,910 | $9.49 | $155,124 | 1,453,098 | — | plan? |
| May 4, 2015 ACDFForm 4 → | May 6, 8:19 pm EDT | Michael DinermanChief Operating Officer | 1,115,616 | $9.49 | $82,791 | 694,116 | — | plan? |
| May 4, 2015 AFForm 4 → | May 6, 7:20 pm EDT | Michael MorneauChief Financial Officer | 77,404 | $9.49 | $98,734 | 77,404 | — | plan? |
| May 4, 2015 ADFForm 4 → | May 6, 7:18 pm EDT | Rochelle HanleyChief Medical Officer | 235,761 | $9.49 | $69,353 | 168,855 | — | plan? |
| May 4, 2015 PForm 4 → | May 5, 1:47 pm EDT | Matthew W FoehrDirector | 6,250 | $8.00 | $50,000 | 6,250 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 AForm 4 → | Aug 7, 4:34 pm EDT | Dorothy Elizabeth Kelly-GemmellDirector | 40,800 | — | — | 40,800 | — | late |
| Jun 1, 2026 AForm 4 → | Jun 3, 7:44 pm EDT | Hubert C ChenChief Medical Officer | 190,000 | — | — | 190,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 3, 8:35 pm EST | Michael MorneauVP, Finance and Administration | 29,000 | — | — | 29,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 3, 8:33 pm EST | Hiroko MasamuneChief Development Officer | 66,000 | — | — | 66,000 | — | |
| Jan 3, 2019 AForm 4 → | Jan 3, 8:31 pm EST | Brian LianPresident & CEO, Director | 235,554 | — | — | 235,554 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 8:28 pm EST | Stephen W WebsterDirector | 22,000 | — | — | 22,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 8:27 pm EST | J Matthew SingletonDirector | 22,000 | — | — | 22,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 8:26 pm EST | Matthew W FoehrDirector | 22,000 | — | — | 22,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 8:22 pm EST | Lawson MacartneyDirector | 22,000 | — | — | 22,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 8:20 pm EST | Charles A Rowland Jr.Director | 22,000 | — | — | 22,000 | — | |
| Jul 1, 2018 AForm 4 → | Jul 3, 5:25 pm EDT | Hiroko MasamuneChief Development Officer | 42,000 | — | — | 42,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 5:42 pm EST | Michael MorneauChief Financial Officer | 52,500 | — | — | 52,500 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 5:41 pm EST | Brian LianPresident & CEO, Director | 140,000 | — | — | 140,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 4:18 pm EST | Stephen W WebsterDirector | 16,000 | — | — | 16,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 4:17 pm EST | J Matthew SingletonDirector | 16,000 | — | — | 16,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 4:17 pm EST | Charles A Rowland Jr.Director | 16,000 | — | — | 16,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 4:16 pm EST | Lawson MacartneyDirector | 16,000 | — | — | 16,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 4:15 pm EST | Matthew W FoehrDirector | 16,000 | — | — | 16,000 | — | |
| Jul 13, 2017 JForm 4 → | Sep 27, 2018, 9:25 pm EDT | LIGAND PHARMACEUTICALS INC10% Owner | 1,955,139 | $1,879,405.52 | $3,674,499,023,981 | 0 | — | late |
| Jul 1, 2017 AForm 4 → | Jul 5, 9:34 pm EDT | Charles A Rowland Jr.Director | 40,000 | — | — | 40,000 | — | |
| Jan 5, 2017 AForm 4 → | Jan 5, 7:20 pm EST | Michael MorneauChief Financial Officer | 112,605 | — | — | 17,605 | — | |
| Jan 5, 2017 AForm 4 → | Jan 5, 7:20 pm EST | Brian LianPresident & CEO, Director | 284,931 | — | — | 34,931 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:18 pm EST | Matthew W FoehrDirector | 16,000 | — | — | 16,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:17 pm EST | J Matthew SingletonDirector | 16,000 | — | — | 16,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:16 pm EST | Stephen W WebsterDirector | 16,000 | — | — | 16,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:15 pm EST | Lawson MacartneyDirector | 16,000 | — | — | 16,000 | — | |
| Apr 13, 2016 ACJForm 4 → | Apr 15, 5:19 pm EDT | LIGAND PHARMACEUTICALS INC10% Owner | 2,270,000 | $30,001.00 | $22,500,750,000 | 1,955,139 | — | |
| Apr 13, 2016 PForm 4 → | Apr 13, 6:17 pm EDT | Matthew W FoehrDirector | 20,000 | $0.01 | $200 | 20,000 | — | |
| Mar 14, 2016 AForm 4 → | Mar 15, 4:18 pm EDT | Michael MorneauChief Financial Officer | 19,934 | — | — | 19,934 | — | |
| Mar 14, 2016 AForm 4 → | Mar 15, 4:18 pm EDT | Brian LianPresident & CEO, Director | 54,336 | — | — | 54,336 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 4:53 pm EST | Rochelle HanleyChief Medical Officer | 35,250 | — | — | 35,250 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 4:53 pm EST | Michael MorneauChief Financial Officer | 40,000 | — | — | 40,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 8, 4:52 pm EST | Brian LianPresident & CEO, Director | 125,000 | — | — | 125,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 2:16 pm EST | Stephen W WebsterDirector | 16,000 | — | — | 16,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 2:14 pm EST | J Matthew SingletonDirector | 16,000 | — | — | 16,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 2:11 pm EST | Matthew W FoehrDirector | 16,000 | — | — | 16,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 2:08 pm EST | Lawson MacartneyDirector | 16,000 | — | — | 16,000 | — | |
| May 4, 2015 ACForm 4 → | May 6, 8:20 pm EDT | Brian LianPresident & CEO, Director | 87,500 | — | — | 0 | — | |
| May 4, 2015 ACForm 4 → | May 6, 8:19 pm EDT | Michael DinermanChief Operating Officer | 45,000 | — | — | 3,642 | — | |
| May 4, 2015 AForm 4 → | May 6, 7:20 pm EDT | Michael MorneauChief Financial Officer | 25,500 | — | — | 25,500 | — | |
| May 4, 2015 AForm 4 → | May 6, 7:18 pm EDT | Rochelle HanleyChief Medical Officer | 30,000 | — | — | 30,000 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 9:21 pm EDT | Stephen W WebsterDirector | 20,786 | — | — | 20,786 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 9:19 pm EDT | Lawson MacartneyDirector | 20,786 | — | — | 20,786 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 9:17 pm EDT | Matthew W FoehrDirector | 20,786 | — | — | 20,786 | — | |
| Apr 28, 2015 AForm 4 → | Apr 30, 9:15 pm EDT | J Matthew SingletonDirector | 20,786 | — | — | 20,786 | — |